Misoprostol for abortion at 9-12 weeks' gestation in adolescents

European Journal of Contraception and Reproductive Health Care

Volumn 6, Issue 1, 2001, Pages 39-45

  Carbonell, J L L ^a   Velazco, A ^b   Varela, L ^b   Tanda, R ^b   Sanchez C ^b   Barambio, S ^c   Chami, S ^d   Valero, F ^e   Aragon S ^a   Mari J ^a  

^a Mediterranea Medica Clinic   (Spain)

^b Hospital Gineco Obstétrico 'Eusebio Hernández' Maternidad Obrera   (Cuba)

^c Clinica Tutor Medica   (Spain)

^d Clinica Isadora   (Spain)

^e Clinica Delta Medica   (Spain)

Author keywords

Abortion; Adolescents; Misoprostol

Indexed keywords

HEMOGLOBIN; MISOPROSTOL;

ABORTION; ADOLESCENT; ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; NAUSEA; PREGNANCY TERMINATION; PRIORITY JOURNAL; VAGINA BLEEDING; VOMITING;

EID: 0035031446     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/ejc.6.1.39.45     Document Type: Article

References (16)

1. Pregnancy, abortion and birth rates among US adolescents- 1980, 1985, and 1990
2. Methotrexate and misoprostol for early abortion in adolescent women
3. The use of misoprostol for termination of early pregnancy
4. The use of misoprostol for abortion of 9 weeks gestation
5. Early abortion with 800 g of misoprostol by the vaginal route
6. Misoprostol for abortion up to 9 weeks gestation in adolescents
7. Vaginal misoprostol for late first trimester abortion
8. Vaginal misoprostol for abortion at 10-13 weeks' gestation
9. Termination of pregnancy at 9-13 weeks amenorrhoea with mifepristone and misoprostol
10. Medical termination of pregnancy at 63 to 83 days gestation
11. Growth and development of the human fetus prior to the twentieth week of gestation
12. Analysis of failure in medical abortion
13. Approaches to sample size estimations in the design of clinical trials
14. Vaginal misoprostol for early second trimester abortion